Cellectis S.A.
CMVLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $136 | $170 | $95 | $363 |
| - Cash | $143 | $137 | $98 | $186 |
| + Debt | $91 | $85 | $76 | $101 |
| Enterprise Value | $84 | $119 | $73 | $278 |
| Revenue | $42 | $1 | $19 | $74 |
| % Growth | 5,397.5% | -96.1% | -74.1% | – |
| Gross Profit | $42 | $0 | $17 | $38 |
| % Margin | 100% | 2.4% | 90.8% | 50.9% |
| EBITDA | -$15 | -$93 | -$76 | -$83 |
| % Margin | -36.5% | -12,269.7% | -398.4% | -112.4% |
| Net Income | -$37 | -$103 | -$106 | -$81 |
| % Margin | -88.6% | -13,665.4% | -553.6% | -109.6% |
| EPS Diluted | -0.41 | -1.77 | -2.33 | -1.81 |
| % Growth | 76.8% | 24% | -28.7% | – |
| Operating Cash Flow | $23 | -$25 | -$87 | -$105 |
| Capital Expenditures | -$4 | -$1 | -$2 | -$20 |
| Free Cash Flow | $19 | -$26 | -$90 | -$124 |